Rsv Vaccine, Mrna Dosage

Medically reviewed by Drugs.com. Last updated on Jul 16, 2024.

Applies to the following strengths: preservative-free

Usual Adult Dose for Vaccination

60 years and older: 0.5 mL IM as a single dose

Use: For active immunization for the prevention of lower respiratory tract disease caused by RSV

Data not available

Data not available

CONTRAINDICATIONS:

History of a severe allergic reaction (e.g., anaphylaxis) to the active component or any of the ingredients

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Data not available

Administration advice:

Storage requirements:

Minimize exposure to room light and avoid exposure to direct sunlight and UV light.
Frozen storage: Store frozen between -40C to -15C (-40F to 5F).
Storage after thawing:
Prefilled syringes may be stored refrigerated between 2C to 8C (36F to 46F) for up to 30 days before use.
Prefilled syringes may be stored between 8C to 25C (46F to 77F) for a total of 24 hours after removal from refrigerated conditions; discard if not used within this time. Do not return syringes to the refrigerator after being thawed at room temperature.
Do not refreeze after thawing.

Reconstitution/preparation techniques:

The frozen suspension in the prefilled syringe must be thawed before administration.
Thaw each syringe before use, either in the refrigerator or at room temperature.
The manufacturer product information should be consulted for thawing condition and times.

General:

This drug is a white to off-white suspension that may contain visible white or translucent product-related particulates; do not administer if it is discolored or contains other particulate matter.

Patient advice:

Read the US FDA-approved patient labeling (Information for Recipients and Caregivers).
Report any adverse events to your health care provider or to the Vaccine Adverse Event Reporting System at 1-800-822-7967 and www.vaers.hhs.gov.